Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma

Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma

Bibliographic Details
Main Authors:	Kim, Ryul, Keam, Bhumsuk, Kwon, Dohee, Ock, Chan-Young, Kim, Miso, Kim, Tae Min, Kim, Hak Jae, Jeon, Yoon Kyung, Park, In Kyu, Kang, Chang Hyun, Kim, Dong-Wan, Kim, Young Tae, Heo, Dae Seog
Format:	Online
Language:	English
Published:	Baishideng Publishing Group Inc 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055869/

Similar Items

Prognostic implications of FGFR1 and MYC status in esophageal squamous cell carcinoma
by: Kwon, Dohee, et al.
Published: (2016)

The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
by: Kim, Ryul, et al.
Published: (2016)

Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study
by: Kim, Ryul, et al.
Published: (2016)

Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination Chemotherapy
by: Kim, Miso, et al.
Published: (2015)

Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute
by: Choi, Younak, et al.
Published: (2015)

The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer
by: Lee, June-Koo, et al.
Published: (2015)

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
by: Ock, Chan-Young, et al.
Published: (2016)

Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations
by: Park, Sehhoon, et al.
Published: (2016)

Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure
by: Cho, Kyoung Min, et al.
Published: (2015)

MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system
by: Kim, Sehui, et al.
Published: (2016)

Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era
by: Ha, Hyerim, et al.
Published: (2016)

Pretreatment neutrophil‐lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor‐mutant non‐small cell lung cancer patients treated with tyrosine kinase inhibitors
by: Sim, Sung Hoon, et al.
Published: (2015)

Clinical Prognostic Factors for Locally Advanced Esophageal Squamous Carcinoma Treated after Definitive Chemoradiotherapy
by: Kim, Dae-Eun, et al.
Published: (2013)

Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma
by: Yang, Zhao-Ting, et al.
Published: (2016)

Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation
by: Ock, Chan-Young, et al.
Published: (2016)

The Prognostic Significance of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma
by: Ha, Sang Yun, et al.
Published: (2014)

Invasion of the great vessels or atrium predicts worse prognosis in thymic carcinoma
by: Eom, Keun-Yong, et al.
Published: (2013)

How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution
by: Keam, Bhumsuk, et al.
Published: (2013)

Gefitinib-Induced Interstitial Lung Disease in Korean Lung Cancer Patients
by: Beom, Seung-Hoon, et al.
Published: (2016)

Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
by: Keam, Bhumsuk, et al.
Published: (2014)

ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy
by: Kim, Hee-Jun, et al.
Published: (2015)

Role of Postoperative Radiotherapy for Microscopic Margin Involvement in the Squamous Cell Carcinoma of Esophagus
by: Song, Sanghyuk, et al.
Published: (2013)

Esophageal Stent Insertion for Postesophagectomy Anastomosis Site Leakage
by: Kim, Sang Yoon, et al.
Published: (2016)

A Case of Esophageal Squamous Papillomatosis
by: Park, Sang-Hyun, et al.
Published: (2012)

Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma
by: Chen, Kaiyan, et al.
Published: (2016)

Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations
by: Park, Sehhoon, et al.
Published: (2015)

Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma
by: Kim, Hyo Song, et al.
Published: (2015)

Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy
by: Wee, Chan Woo, et al.
Published: (2015)

Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma
by: Yun, Tak, et al.
Published: (2011)

Definitive Radiotherapy versus Postoperative Radiotherapy for Tonsil Cancer
by: Koo, Tae Ryool, et al.
Published: (2012)

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
by: Keam, Bhumsuk, et al.
Published: (2011)

VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma
by: Park, Seongyeol, et al.
Published: (2016)

Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis
by: Cha, Soojin, et al.
Published: (2016)

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
by: Keam, Bhumsuk, et al.
Published: (2007)

Influence of Comorbidities on the Efficacy of Radiotherapy with or without Chemotherapy in Elderly Stage III Non-small Cell Lung Cancer Patients
by: Lee, Joo Ho, et al.
Published: (2012)

A Case of Esophageal Squamous Cell Carcinoma with Pancreatic Metastasis
by: Park, Choulki, et al.
Published: (2013)

Adenoid Cystic Carcinoma of the Breast: A Case Series of Six Patients and Literature Review
by: Kim, Miso, et al.
Published: (2014)

Clinical Analysis of Primary Eosinophilic Esophagitis
by: Lee, Jung Ho, et al.
Published: (2013)

Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
by: Yang, Yaewon, et al.
Published: (2016)

The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy
by: Shim, Hyun-Jeong, et al.
Published: (2016)